We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current MYX market cap is 588.29M. The company's latest EPS is AUD 1.3782 and P/E is 5.01.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 525.21M | 456.99M | 400.78M | 400.93M | 262.48M |
| Operating Income | -337.9M | -104.12M | -230.15M | -11.86M | -233.15M |
| Net Income | -280.87M | -92.79M | -208.42M | -281.29M | 117.25M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 1.64B | 1.83B | 1.46B | 1.29B | 1.25B |
| Total Liabilities | 622.26M | 782.87M | 691.61M | 749.7M | 612.99M |
| Total Equity | 1.01B | 1.04B | 771.58M | 538.23M | 634.36M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | 106.61M | 99.78M | 58.86M | -7.21M | -42.71M |
| Investing | -91.69M | -55.87M | -49.25M | -28.53M | 473.49M |
| Financing | -15.55M | 4.52M | -40.44M | 27.6M | -431.89M |
| Market Cap | 588.29M |
| Price to Earnings Ratio | 5.01 |
| Price to Sales Ratio | 2.24 |
| Price to Cash Ratio | 6.35 |
| Price to Book Ratio | 0.93 |
| Dividend Yield | - |
| Shares Outstanding | 85.07M |
| Average Volume (1 week) | 150.75k |
| Average Volume (1 Month) | 181.58k |
| 52 Week Change | 70.74% |
| 52 Week High | 7.40 |
| 52 Week Low | 2.75 |
| Spread (Intraday) | 0.03 (0.43%) |
| Company Name | Mayne Pharma Group Ltd |
| Address |
1538 main north road adelaide, south australia 5106 |
| Website | https://www.maynepharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
